Date: 29-Aug-2019

Ascletis receives IND approval for its NASH drug

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases